MIDAZOLAM
| Brand name | MIDAZOLAM IN 0.9% SODIUM CHLORIDE |
|---|---|
| Active ingredient | MIDAZOLAM |
| Strength | 50MG/50ML (1MG/ML) |
| Dosage form | SOLUTION |
| Route | INTRAVENOUS |
| Modality | Small molecule |
| FDA approval | March 2021 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 10966990 | June 2038 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.